Closed Blood Sampling Systems

Closed Blood Sampling Systems Market Outlook

The global Closed Blood Sampling Systems Market is projected to reach a size of approximately USD 3.5 billion by 2035, reflecting a compound annual growth rate (CAGR) of around 8.2% during the forecast period from 2025 to 2035. This growth in market size is attributed to the increasing prevalence of chronic diseases, the rising demand for effective diagnostic tools, and the growing adoption of innovative healthcare solutions aimed at improving patient safety and comfort. The advancements in technology, coupled with the increasing focus on preventive healthcare, are further propelling the market's expansion. Additionally, the increasing awareness of the benefits of closed blood sampling systems, such as minimizing contamination risks and enhancing patient comfort, is expected to contribute significantly to market growth.

Growth Factor of the Market

One of the primary growth factors driving the Closed Blood Sampling Systems Market is the rising incidence of chronic diseases, which necessitates regular blood testing and monitoring. Conditions such as diabetes, cardiovascular diseases, and infections have surged in prevalence, creating a demand for safe and reliable blood sampling systems. Furthermore, technological advancements in closed blood sampling technologies have transformed the way blood is collected, enabling healthcare facilities to enhance patient safety and reduce the risk of exposure to infectious diseases. The increasing focus on minimizing the risk of needle-stick injuries among healthcare workers also plays a significant role in the market's growth. Additionally, the growing trend towards point-of-care testing is propelling the demand for closed blood sampling systems, as they facilitate quick and accurate results in diverse settings. All these factors combined are expected to create a positive outlook for the market in the coming years.

Key Highlights of the Market

• The Closed Blood Sampling Systems Market is expected to grow at a CAGR of 8.2% from 2025 to 2035.
• Technological advancements are enhancing patient safety and comfort during blood collection.
• The increasing prevalence of chronic diseases is driving demand for reliable blood sampling solutions.
• Point-of-care testing is becoming a significant trend, supporting the growth of this market.
• Rising awareness among healthcare professionals regarding the benefits of closed systems is fostering market expansion.

By Product Type

Vacutainer Systems:

Vacutainer Systems, a leading segment in the Closed Blood Sampling Systems Market, are designed to collect blood samples safely and efficiently. These systems utilize vacuum technology, which enables the collection of a consistent volume of blood without requiring excessive manual handling. The convenience and efficiency offered by Vacutainer Systems have made them popular in clinical laboratories and hospitals worldwide. Furthermore, their compatibility with various blood tests increases their utility, creating a robust market presence. The continuous innovations in the design and materials used for Vacutainer Systems further enhance their appeal, as manufacturers strive to improve safety features and user-friendliness. As hospitals and clinics continue to adopt advanced blood collection technologies, the demand for Vacutainer Systems is expected to grow significantly.

Safety Blood Sampling Systems:

Safety Blood Sampling Systems are designed to minimize the risk of needle-stick injuries, which are a significant concern in healthcare settings. These systems incorporate retractable needles and safety features that ensure blood collection is conducted with the utmost safety for both healthcare professionals and patients. The growing awareness of workplace safety and the increasing regulation surrounding occupational health are driving the adoption of Safety Blood Sampling Systems. Moreover, the rise in the number of procedures requiring blood collection in hospitals and outpatient settings has fueled market demand. The focus on improving the user experience and minimizing the risk of infection is also a significant factor contributing to the growth of this segment, making Safety Blood Sampling Systems a vital component of the overall market.

Micro-collection Systems:

Micro-collection Systems have gained traction as a convenient and minimally invasive alternative for blood sample collection. These systems are particularly useful for pediatric patients and those requiring frequent blood tests, as they utilize smaller volumes of blood, reducing discomfort and anxiety. The rising trend of home healthcare and point-of-care testing further supports the market demand for Micro-collection Systems. Their ability to facilitate quick and accurate results while minimizing the risk of contamination makes them an attractive option for both healthcare providers and patients. Additionally, ongoing innovations in micro-collection technology—such as enhanced collection tubes and improved capillary blood collection devices—are expected to drive the growth of this segment in the forthcoming years.

Capillary Blood Collection Systems:

Capillary Blood Collection Systems are another vital segment of the Closed Blood Sampling Systems Market, primarily utilized for collecting small blood samples from the capillaries. This approach is especially advantageous for infants and patients with difficult venous access. Capillary sampling is favored for its convenience, quick processing times, and the reduced amount of blood required for testing. The growing adoption of capillary blood testing across various applications, including diabetes monitoring and point-of-care diagnostics, is propelling the market for these systems. The rise in at-home testing and the increasing emphasis on patient-centered care further enhance the relevance of Capillary Blood Collection Systems, supporting their expected growth trajectory.

Blood Sampling Tubes:

Blood Sampling Tubes represent an essential component of the Closed Blood Sampling Systems, as they are used to safely transport and store collected blood samples for analysis. These tubes come in various designs, materials, and additives, catering to different testing requirements. The market for blood sampling tubes is expanding due to the increasing demand for precise and accurate blood tests across medical facilities. Innovations in tube design, such as enhancements in material strength, anti-contamination features, and user-friendly cap designs, are also contributing to market growth. Furthermore, the growing focus on laboratory efficiency and the need for standardized procedures in blood collection are driving the adoption of advanced blood sampling tubes. Overall, this segment is poised for significant growth in the coming years.

By Application

Hospitals:

Hospitals represent the largest application segment for Closed Blood Sampling Systems, as they are the primary providers of healthcare services and conduct numerous diagnostic procedures. The increasing patient influx and the demand for timely diagnosis and treatment have led hospitals to adopt advanced blood collection systems that enhance safety and efficiency. With the growing prevalence of chronic diseases and the need for regular monitoring, hospitals are increasingly relying on closed blood sampling systems to ensure patient safety and improve clinical outcomes. Furthermore, the focus on reducing healthcare-associated infections has prompted hospitals to invest in innovative sampling technologies, further solidifying the position of hospitals as a key application area in this market.

Clinics:

Clinics are another vital application area for Closed Blood Sampling Systems, serving outpatient services and routine diagnostic tests. As the trend toward preventive healthcare continues to rise, clinics require reliable blood sampling systems to facilitate various tests efficiently. The convenience offered by closed systems is particularly attractive to clinics, enabling them to provide quick and accurate test results. The growing trend of decentralized healthcare and the increasing number of diagnostic services provided at clinics are driving the demand for closed blood sampling systems in this segment. Additionally, innovations in micro-collection systems and point-of-care testing devices have further increased the appeal of closed blood sampling solutions within clinical environments.

Diagnostic Centers:

Diagnostic Centers play a crucial role in the healthcare ecosystem by providing specialized testing services, including blood analysis. The increasing demand for accurate diagnostic testing and the rising volume of blood samples processed at these centers are driving the adoption of closed blood sampling systems. The implementation of these systems enhances efficiency, reduces contamination risks, and ensures accurate test results, thereby improving patient care. Furthermore, the emphasis on laboratory quality control and the need for standardized blood collection protocols are propelling diagnostic centers to adopt advanced sampling technologies. As the focus on timely diagnosis continues to grow, closed blood sampling systems will remain integral to the operations of diagnostic centers.

Blood Banks:

Blood Banks are critical facilities that rely heavily on effective blood sampling systems for safe collection, processing, and storage of blood donations. The need for stringent safety measures and contamination prevention in blood banks has driven the demand for closed blood sampling systems. These systems facilitate the safe collection of blood from donors, ensuring that the blood is preserved for transfusion purposes without compromising its quality. The rising awareness of blood donation and the increasing number of blood donation drives also contribute to the demand for advanced sampling systems in blood banks. As blood banks continue to enhance their operational efficiency and safety protocols, closed blood sampling systems will play a vital role in their processes.

Home Care Settings:

The Home Care Settings application segment is gaining prominence due to the growing trend of at-home healthcare services and patient-centered care models. Closed blood sampling systems are increasingly being adopted for home use, allowing patients to conduct blood tests conveniently and accurately in the comfort of their homes. This approach not only improves patient adherence to monitoring their health but also minimizes the need for hospital visits. The rise in chronic diseases requiring regular monitoring, such as diabetes, has also driven the demand for at-home blood testing systems. With advancements in technology enabling safe and efficient blood collection at home, this segment is expected to witness significant growth in the coming years, making it a crucial aspect of the closed blood sampling systems market.

By Distribution Channel

Hospitals:

Hospitals are one of the primary distribution channels for Closed Blood Sampling Systems, as they not only use these systems extensively but also serve as key purchasers for their supply. The increasing demand for efficient and reliable blood collection systems within hospitals has led to significant investments in advanced technologies. Hospitals often establish long-term relationships with suppliers to ensure a steady supply of closed blood sampling systems, focusing on quality and safety. The growing prevalence of chronic diseases and the need for regular blood testing in hospitals further accentuate the importance of this distribution channel. Additionally, competitive pricing and effective supply chain management are also critical factors influencing purchasing decisions in hospital settings.

Online Stores:

Online Stores have emerged as a significant distribution channel for Closed Blood Sampling Systems, particularly highlighting the convenience and accessibility of acquiring medical supplies. The growing trend of e-commerce in the healthcare sector allows hospitals, clinics, and individual consumers to order closed blood sampling systems easily. This channel is especially beneficial for smaller healthcare facilities that may lack direct access to suppliers. The rise in demand for home healthcare products has also contributed to the growth of online sales, as consumers seek convenient options for purchasing blood collection systems. Furthermore, the increasing digitization of the healthcare sector and the availability of comprehensive product information online drive the continued expansion of this distribution channel.

Retail Pharmacies:

Retail Pharmacies serve as vital distribution points for Closed Blood Sampling Systems, catering to the needs of individual consumers and healthcare professionals. With the growing trend towards self-care and home testing, retail pharmacies are increasingly stocking various blood sampling products to meet consumer demand. This distribution channel plays a significant role in enhancing accessibility to closed blood sampling systems for patients who may require regular testing. Additionally, the presence of trained pharmacy staff who can provide guidance on product selection further enhances the retail pharmacy's role in the market. As consumer awareness of the importance of regular health monitoring increases, retail pharmacies are likely to see continued growth in this distribution channel.

Diagnostic Centers:

Diagnostic Centers play a crucial role in distributing Closed Blood Sampling Systems, as they are directly involved in the testing and analysis of blood samples. These centers rely on various suppliers to source advanced blood sampling systems that enhance their operational efficiency and safety. The increasing volume of tests conducted at diagnostic centers drives the demand for reliable and innovative blood collection systems, ensuring accurate results for patients. Moreover, as diagnostic centers expand their services and technologies, they seek out the latest advancements in closed blood sampling systems to remain competitive and meet evolving healthcare standards. The close partnership between diagnostic centers and suppliers facilitates the distribution of high-quality blood sampling systems tailored to their specific needs.

Others:

The 'Others' distribution channel category encompasses various alternative avenues through which Closed Blood Sampling Systems can be acquired. These may include specialty medical supply stores, direct sales by manufacturers, and procurement through medical equipment distributors. This channel caters to diverse customer needs, including smaller healthcare facilities and individualized patients looking for specialized blood sampling solutions. The flexibility offered by various distribution options enables healthcare providers to access the systems most suited to their operational requirements. Additionally, as the market for closed blood sampling systems continues to grow, suppliers are likely to expand their reach through multiple distribution channels to meet the demand effectively.

By Material Type

Plastic:

Plastic is one of the predominant material types used in the manufacturing of Closed Blood Sampling Systems, owing to its lightweight, durable, and cost-effective properties. Plastic sampling tubes, containers, and other components are widely adopted due to their versatility and ability to be molded into various shapes and sizes. The use of plastic materials also offers advantages such as resistance to shattering, which is essential for the safe handling of blood samples. Innovations in plastic technology have led to the development of specialized formulations that enhance the performance and safety of closed blood sampling systems. Furthermore, the growing emphasis on single-use products in healthcare settings has driven the demand for plastic-based sampling solutions, ensuring a safer and more hygienic blood collection process.

Glass:

Glass remains a significant material type used in the production of Closed Blood Sampling Systems, particularly for blood collection tubes. Glass offers several advantages, including its inert nature, which prevents reactions with blood samples, and its ability to maintain sample integrity during storage. The demand for glass blood sampling tubes is driven by the need for high-accuracy testing and reliability in laboratory environments. Despite being heavier and more expensive than plastic, glass tubes are preferred for certain diagnostic tests where sample quality is paramount. The increasing focus on laboratory quality control and the demand for precision in blood testing are likely to sustain the market for glass-based sampling systems. Moreover, advancements in glass manufacturing techniques are continually improving the usability and safety of glass blood collection products.

By Region

The Closed Blood Sampling Systems Market exhibits varying growth trends across different regions, influenced by healthcare infrastructure, technological advancements, and demand for diagnostic services. North America holds a substantial share of the market, driven by the advanced healthcare system, high prevalence of chronic diseases, and increasing investments in healthcare technology. The region is expected to witness a CAGR of around 8.5% during the forecast period, propelled by innovations in blood sampling technologies and a growing focus on patient safety. Additionally, regulatory support and the presence of key market players contribute to this region's strong market position. In contrast, the Asia Pacific region is anticipated to experience rapid growth, driven by rising healthcare expenditure, increasing patient awareness, and an expanding population base. The demand for closed blood sampling systems in emerging markets is expected to accelerate as healthcare facilities aim to improve service quality and patient outcomes.

Europe is another significant region for the Closed Blood Sampling Systems Market, with a growing emphasis on reducing healthcare-associated infections and improving patient comfort during blood collection. The region benefits from a robust healthcare framework and a high level of regulatory compliance, driving the adoption of advanced blood sampling technologies. Latin America and the Middle East & Africa also present growth opportunities, albeit at a slower pace, as healthcare systems continue to evolve and investments in healthcare infrastructure increase over time. The focus on improving healthcare accessibility and patient-centered care is expected to foster demand for closed blood sampling systems across these regions, contributing to the overall market expansion.

Opportunities

One of the prominent opportunities in the Closed Blood Sampling Systems Market lies in the increasing trend of home healthcare services. As more patients seek to manage their health conditions from the comfort of their homes, the demand for convenient blood sampling systems is on the rise. This shift is driven by the growing prevalence of chronic diseases, such as diabetes and hypertension, which require regular monitoring and testing. Companies that focus on developing user-friendly, safe, and reliable closed blood sampling solutions designed for home use stand to benefit from this trend. Additionally, the potential for telemedicine integration into home healthcare solutions further enhances opportunities for closed blood sampling systems, creating new pathways for innovation and growth within the sector.

Another opportunity for market expansion is the potential for developing advanced technologies that enhance the efficiency and efficacy of blood sampling systems. Innovations such as smart blood collection devices equipped with digital analytics and real-time monitoring capabilities can revolutionize the blood sampling process. As healthcare continues to evolve towards personalized and data-driven approaches, companies that invest in research and development to create next-generation closed blood sampling systems will likely gain a competitive edge. Collaborations with healthcare providers and research institutions can also pave the way for new product development, ensuring that the solutions meet the ever-changing demands of the healthcare landscape.

Threats

Despite the promising growth trajectory of the Closed Blood Sampling Systems Market, several threats could hinder its progress. One of the primary concerns is the intense competition among manufacturers, leading to price wars and reduced profit margins. As more companies enter the market, there is a risk that competition could drive down prices, affecting the viability of smaller players who may struggle to maintain profitability. Additionally, stringent regulatory requirements and compliance standards imposed by health authorities can create barriers to entry for new market entrants, potentially limiting innovation and slowing the introduction of new products. The dynamic nature of the healthcare market, influenced by changing patient needs and technological advancements, poses a continuous challenge for companies to adapt and remain relevant.

Moreover, the threat of economic downturns and fluctuations in healthcare budgets could impact the purchasing power of healthcare facilities, leading to reduced investments in advanced blood sampling technologies. Economic uncertainties may force hospitals and clinics to postpone or limit their procurement of innovative closed blood sampling systems, adversely affecting market growth. The reliance on healthcare infrastructure and governmental support for procurement of medical equipment can further exacerbate these vulnerabilities, making it essential for market players to navigate these challenges effectively to sustain growth.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Greiner Bio-One International GmbH
• Cardinal Health, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Eppendorf AG
• Haemonetics Corporation
• Medtronic plc
• Smiths Medical
• Sekisui Medical Co., Ltd.
• HemoCue AB
• Omega Laboratories, Inc.
• Vygon SA
• Trinity Biotech plc

The competitive landscape of the Closed Blood Sampling Systems Market is characterized by the presence of several established players and emerging companies striving for market share. Key manufacturers are focusing on research and development to innovate and enhance their product offerings, ensuring they are aligned with the evolving needs of healthcare providers and patients. Additionally, companies are adopting strategic collaborations, partnerships, and mergers to expand their market presence and leverage shared expertise in product development. The emphasis on safety, efficiency, and user-friendliness in blood sampling systems is driving companies to invest heavily in technology and quality control, ultimately leading to better patient outcomes.

BD (Becton, Dickinson and Company) is a prominent player in the Closed Blood Sampling Systems Market, known for its extensive range of medical technologies and devices. The company has a strong presence in the blood collection market with its innovative Vacutainer systems that enhance safety and efficiency during blood sampling. BD's commitment to research and development ensures that its product offerings are continuously improved and compliant with regulatory standards. Additionally, the organization's global reach and extensive distribution network enable it to effectively serve diverse healthcare markets, contributing to its competitive advantage.

Another significant player, Terumo Corporation, specializes in manufacturing a wide array of medical devices, including closed blood sampling systems. The company is recognized for its commitment to quality and safety, with products designed to minimize contamination risks and enhance patient comfort. Terumo's focus on innovation is evident in its development of advanced blood collection technologies that cater to the needs of both healthcare providers and patients. Through strategic partnerships and collaborations with healthcare institutions, Terumo continues to expand its presence in the global market, positioning itself as a leader in closed blood sampling solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vygon SA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 HemoCue AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Eppendorf AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Trinity Biotech plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Cardinal Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Haemonetics Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Omega Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 F. Hoffmann-La Roche Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Sekisui Medical Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Greiner Bio-One International GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Closed Blood Sampling Systems Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Blood Banks
    • 6.1.5 Home Care Settings
  • 6.2 Closed Blood Sampling Systems Market, By Product Type
    • 6.2.1 Vacutainer Systems
    • 6.2.2 Safety Blood Sampling Systems
    • 6.2.3 Micro-collection Systems
    • 6.2.4 Capillary Blood Collection Systems
    • 6.2.5 Blood Sampling Tubes
  • 6.3 Closed Blood Sampling Systems Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Glass
  • 6.4 Closed Blood Sampling Systems Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Online Stores
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Diagnostic Centers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Closed Blood Sampling Systems Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Closed Blood Sampling Systems market is categorized based on

By Product Type

• Vacutainer Systems
• Safety Blood Sampling Systems
• Micro-collection Systems
• Capillary Blood Collection Systems
• Blood Sampling Tubes

By Application

• Hospitals
• Clinics
• Diagnostic Centers
• Blood Banks
• Home Care Settings

By Distribution Channel

• Hospitals
• Online Stores
• Retail Pharmacies
• Diagnostic Centers
• Others

By Material Type

• Plastic
• Glass

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Greiner Bio-One International GmbH
• Cardinal Health, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Eppendorf AG
• Haemonetics Corporation
• Medtronic plc
• Smiths Medical
• Sekisui Medical Co., Ltd.
• HemoCue AB
• Omega Laboratories, Inc.
• Vygon SA
• Trinity Biotech plc